As GLP-1 medications reshape how Americans eat, live and play, the entire CPG ecosystem needs to understand the changes afoot in trip missions, retailer choice, category dynamics and attribute saliency. We'll take a deep dive into new proprietary insights on the changing shopper journey and evolving category decision trees, supported by quantitative rigor and qualitative shopper videography. We'll also hear from Weis Markets' Bob Gleeson and David Goseon the strategic implications for better meeting future shoppers' needs and aspirations.